TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Time to discharge from the operating room
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Nausea NRS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total dose of antiemetic drugs administered
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: DHI scores improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: decreased caregiver burden
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: decreased impact of depression on daily life
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Tolerating clear oral fluids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Normalization of β-HCG below 70,000 mIU/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to successful β-HCG resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: excessive weight gain at end pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prevalence of depression at end pregnancy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: increase in pain experienced during the procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients losing at least 5% of baseline body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients losing at least 10% of baseline body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fatal and non-fatal stroke
Endpoint domain: Mortality/survival
Primary endpoint: exacerbation rate/patient/year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean dentin wear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean day of well-being
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Day 3 mean nasal symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Acute Kidney Injury (AKI)
Endpoint domain: Adverse events/effects
Primary endpoint: Annualized total costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of hysteroscopies and/or dilatation and curettages performed
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mortality after 30 days
Endpoint domain: Mortality/survival
Primary endpoint: Mortality 1 year after discharge
Endpoint domain: Mortality/survival
Primary endpoint: Deep sedation events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction with analgesic treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: time to recover to a TOF of 70% following rocuronium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rise in IOP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: average resolution times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lymphocyte counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: average apoptotic half-time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Frequency of adverse airway events
Endpoint domain: Adverse events/effects
Primary endpoint: Mean serum concentration of ALP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Serum ALP and LDH levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Urine albumin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Children's attitudes toward obese peers
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Willingness to share academic activities with obese peers
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Percentage of UTI
Endpoint domain: Adverse events/effects
Primary endpoint: Disease-free time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: adverse events leading to study drug discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: median changes in serum creatinine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Headache prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bronchoprotection vs placebo
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Domiciliary peak flow improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Labor analgesia quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time in subsyndromal depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time in mixed states
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: severity of abdominal pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency of abdominal pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression of WMLs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dye leakage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulmonary wedge pressure (PWP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Frequency of migraine headache
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of migraine headache
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Return to preinjury sports activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Safety profile of lubiprostone
Endpoint domain: Adverse events/effects
Primary endpoint: amount of defect fill
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of paraesthesias
Endpoint domain: Adverse events/effects
Primary endpoint: Time taken for catheter insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Participation rates in organized CRC screening
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of analyzable tests
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Ease of use preference for FOB-Gold vs OC-Sensor
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean decrease in HIT-6 scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Increase in Headache Management Self-Efficacy Scale (HMSE) scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incremental glucose area under the curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to resolution of fever and tachypnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Return of appetite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achievement of 'much improved' or 'cured' status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fecal elastase-1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: healing velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to 50% size reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: early treatment dropout
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Apolipoprotein B (ApoB) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: non-high-density lipoprotein cholesterol (non-HDL-C) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: gestational age at birth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hindbrain herniation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: psychomotor development
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Results in theoretical tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Results in practical tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Results in OSCE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional independence at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cognitive performance at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Health-related quality of life (HRQoL) at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: bone mineral content
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Basal BMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Submaximal exercise VO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Submaximal cardiac output
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: feeding success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent increase in CD34+ cells (%DeltaCD34+)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: baseline untreated IOP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall office visit satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: tear mixing rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of dental pain and/or dental sepsis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of episodes of dental pain and/or dental sepsis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease in vmHRV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrent vascular event (stroke, myocardial infarction, or vascular death)
Endpoint domain: Mortality/survival
Primary endpoint: Increased faecal butyrate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Increased faecal levels of bifidobacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: No adverse effects on gastrointestinal symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: All-cause hospitalizations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative time hospitalized
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of concomitant drugs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Febrile Neutropenia (FN) rates
Endpoint domain: Adverse events/effects
Primary endpoint: mean depression score post treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: day-night blood pressure changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: left ventricular mass index changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean percent reduction in inflammatory lesion counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: percentage of patients 'clear' or 'almost clear'
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean MNA score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: total driving errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of CD34(+) cells collected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Hematopoietic reconstitution time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sPGA-G 0/1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall sPGA 0/1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GenPs-SFQ item 2 score of 0 or 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total dose of drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Binocular distance visual acuity (BDVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Binocular distance contrast sensitivity (BDCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wound healing rate on PBD 30
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total hospital stay days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Incidence of burn sepsis
Endpoint domain: Adverse events/effects
Primary endpoint: Area under the receiver-operating-characteristic curve (AUC(ROC))
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serum bactericidal antibody responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Local anesthetic doses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Curing head lice infestation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pediculicidal effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events (itching, burning, stinging)
Endpoint domain: Adverse events/effects
Primary endpoint: Mandibular prognathism enhancement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower-facial height increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Condylar growth pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CRB rate documented
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of education in HIPPO-ST arm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Contamination rate in control arm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentrations of proinflammatory cytokines IL‐6 and IL‐8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Levels of anti‐inflammatory IL‐10
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Urinary retention during labor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: ephedrine requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean maximum change in forced vital capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Scores in the OR after automaticity training
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical improvement rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall microbiological eradication rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Late potential positivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RMS40 value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ventricular fibrillation recurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Early occurrence of postoperative infections
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment costs of complications
Endpoint domain: Resource use
Primary endpoint: Skin blood flow changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: risk of fracture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Final myocardial salvage index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microvascular obstruction (MVO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for head covering
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerability of the procedure
Endpoint domain: Adverse events/effects
Primary endpoint: RIII threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual acuity loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: food and drink intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: unanticipated healthcare services
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: partial pressures of oxygen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in motion artifacts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiation dose values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total abdominal fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: abdominal subcutaneous fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: AVF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Lower-body strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: 7-year Biochemical Failure-Free Survival (BCFFS)
Endpoint domain: Mortality/survival
Primary endpoint: Postoperative signs and symptoms of muscle weakness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lamotrigine efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean clinical chair time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean laboratory work time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total production time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean final pain level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent cocaine-negative urine toxicology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported abstinence measures
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: treatment retention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fasting and post-prandial plasma glucose levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in halitosis grades
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: global cerebral perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oxygen supply/demand ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vasopressor requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Antidepressant-related sexual dysfunction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: HDRS17 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute oral bioavailability of rosuvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hepatic extraction ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of distribution at steady state
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adult height attainment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of SVG occlusion at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: H.pylori infection eradication rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Unplanned visits to the GP
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Readmission to hospital
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reproducibility of food intake measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Validity of food intake measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: death plus cardiac hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: linear bone gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent defect fill
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes